Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Bully88on Aug 24, 2020 10:54am
142 Views
Post# 31445467

RE:RE:RE:Hold Strong

RE:RE:RE:Hold Strong

not sure where the confusion is.

I can add the list of just straight tests completed at 75$ a test for you so it doesnt show daily, quarterly or years math?
 


Tests Completed Revenue Per Test Total Revenue
1000  $    75.00  $        75,000.00
2000  $    75.00  $      150,000.00
3000  $    75.00  $      225,000.00
4000  $    75.00  $      300,000.00
5000  $    75.00  $      375,000.00
6000  $    75.00  $      450,000.00
7000  $    75.00  $      525,000.00
8000  $    75.00  $      600,000.00
9000  $    75.00  $      675,000.00
10000  $    75.00  $      750,000.00
20000  $    75.00  $  1,500,000.00
30000  $    75.00  $  2,250,000.00
40000  $    75.00  $  3,000,000.00
50000  $    75.00  $  3,750,000.00
60000  $    75.00  $  4,500,000.00
70000  $    75.00  $  5,250,000.00
80000  $    75.00  $  6,000,000.00
90000  $    75.00  $  6,750,000.00
100000  $    75.00  $  7,500,000.00
110000  $    75.00  $  8,250,000.00
120000  $    75.00  $  9,000,000.00
130000  $    75.00  $  9,750,000.00
140000  $    75.00  $10,500,000.00
150000  $    75.00  $11,250,000.00
160000  $    75.00  $12,000,000.00
170000  $    75.00  $12,750,000.00
180000  $    75.00  $13,500,000.00
190000  $    75.00  $14,250,000.00
200000  $    75.00  $15,000,000.00
210000  $    75.00  $15,750,000.00
220000  $    75.00  $16,500,000.00
230000  $    75.00  $17,250,000.00
240000  $    75.00  $18,000,000.00
250000  $    75.00  $18,750,000.00


at 1 million dollars in the first week that puts us at 13,333 tests completed in the first 6 half of the quarter. (highlighted in yellow)

if they match that in the second half, not including growth in production, that puts us at 26,666 tests. highlted in pink (rounded up to 30,000 tests completed cause im lazy on mondays...

So without projecting or expectations, if they continue on the path they are on right now.

we are looking at 2+ million in revenue for q3. 

for a stock thats made 50k a quarter for the last 6 years, that is unfathomable.

only a matter of time before the market realises that this company is printing money.

(cue the Revenue vs Profit definition arguements.)

cheers,

Bully
Bullboard Posts